Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fully Automated Immunoassay Determines Autoantibodies to TSH Receptor

By Labmedica staff writers
Posted on 02 Apr 2008
A fully automated immunoassay has been launched for the determination of autoantibodies to the thyroid-stimulating hormone (TSH) receptor for the differential diagnosis of Graves' disease. More...
The newly developed assay has been shown to meet diagnostic requirements with excellent sensitivity and specificity. The total test time is 27 minutes, which is significantly faster than existing methods.

Graves` disease, which is also known as Basedow's disease, is the main type of autoimmune thyroid disease and is associated with hyperthyroidism and ophthalmopathy. The incidence is about 40 cases per 100,000 population per year. The TSH receptor antibody (TRAb) is the major pathogenic factor in Graves' disease, which, like TSH, binds the receptor and has a stimulatory effect with resulting hyperthyroidism. Measurement of the TSH receptor antibody is recommended in the diagnosis of Graves' disease and differentiation from diffuse thyroid autonomy. TRAb measurement is also used for monitoring antithyroid drug treatment.

The assay has been Conformité Européenne (CE)-approved for use on the Roche Diagnostics (Rotkreuz, Switzerland) Elecsys/cobase electrochemiluminescence immunoassay systems. The Elecsys TSH receptor antibody assay is based on intellectual property owned by RSR Ltd. (Cardiff, UK), a company with which Roche has a license agreement.

The anti-TSHR assay complements Roche Diagnostics' broad immunoassay menu on Elecsys and cobas e platforms, which permit the use of both routine and special assays.

"The new TRAb assay provides the opportunity to perform differential diagnosis of thyroid autoimmune diseases with new levels of accuracy, speed, and degree of automation,” said Dirk Ehlers, head of Roche Diagnostics. "This assay will further strengthen Roche's comprehensive test menu in thyroid diseases and endocrinology.”


Related Links:
Roche Diagnostics
RSR

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.